SAN DIEGO & BOSTON–(BUSINESS WIRE)–SEQSTER, the leading healthcare technology company and the data connection, collection, and orchestration layer for patient health data, and Praxis Precision Medicines, Inc., today announced the expansion of a successful partnership to accelerate clinical trials, data collection, and real-world evidence (RWE) generation across Praxis’s clinical development programs. Building on early success in Praxis’s innovative Essential3 Program for Essential Tremor, SEQ
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
